Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
688506 Sichuan Biokin Pharmaceutical
- 283.00
- 0.000.00%
Not Open Apr 25 09:30 CST
113.48BMarket Cap30.61P/E (TTM)
0.00High0.00Low0lotVolume0.00Open283.00Pre Close0.00Turnover0.00%Turnover Ratio30.61P/E (Static)401.00MShares297.8652wk High29.20P/B26.06BFloat Cap134.5552wk Low339.60Limit Up92.07MShs Float297.86Historical High226.40Limit Down0.00%Amplitude28.75Historical Low--Dividend TTM--Avg Price0lotAsk--Div YieldTTM100Lot Size0lotBid
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Sichuan Biokin Pharmaceutical Stock Forum
December 22, 2023
2142.HK
1.56
(-2.5%)
The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer
Key Takeaways:
Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion
HBM Holdin...
No comment yet